Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VCT220 in Hypertension and Obesity or Overweight
NCT07360275Phase 2Active, not recruiting
- Sponsor
- Vincentage Pharma Co., Ltd.
- Start
- Mar 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VCT220 in hypertension (HTN), obesity, Overweight, sponsored by Vincentage Pharma Co., Ltd.. Started Mar 2026; status: active, not recruiting.
02
Drugs
VCT220
03
Conditions
hypertension (HTN)obesityOverweight
Beyond the preview
Go deeper on NCT07360275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07360275.